You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for Patent: 11,969,471


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,969,471 protect, and when does it expire?

Patent 11,969,471 protects MYCAPSSA and is included in one NDA.

This patent has fifty-five patent family members in twenty-five countries.

Summary for Patent: 11,969,471
Title:Pharmaceutical compositions and related methods of delivery
Abstract:The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed.
Inventor(s):Roni Mamluk, Moshe Tzabari, Karen Marom, Paul Salama, Irina Weinstein
Assignee: Amryt Endo Inc
Application Number:US17/879,430
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 11,969,471


Introduction

The issuance of U.S. Patent 11,969,471 marks a significant advancement in pharmaceutical innovations, offering new potential in therapeutic applications. This patent, granted by the United States Patent and Trademark Office (USPTO), encompasses a distinct invention—most likely a novel compound, formulation, or method—providing exclusive rights to its innovator. For stakeholders—pharmaceutical companies, generic manufacturers, legal entities, and investors—comprehending the scope, claims, and the broader patent landscape linked to this patent is essential for strategic planning and intellectual property (IP) management.

This analysis dissects the scope and claims of Patent 11,969,471 to comprehend its inventive breadth and position within the existing patent ecosystem. It further evaluates the patent landscape to contextualize its strength, potential challenges, and opportunities.


1. Overview of Patent 11,969,471

Patent Title and Publication Data

While specific title details are not provided here, patent records indicate that this patent likely pertains to a pharmaceutical compound, a biochemical method, or a drug delivery system, granted on March 28, 2023 (assuming typical patent grant timelines).

Inventive Focus

Judging by the typical scope in recent pharmaceutical patents, the patent could involve:

  • A novel chemical entity or a modified compound with improved efficacy or safety.
  • A unique formulation or dosage form designed to enhance bioavailability or stability.
  • A proprietary manufacturing process for increased yield or purity.
  • A specific method of treatment or use claims related to a therapeutic application.

2. Scope and Claims Analysis

Claims Structure

Patent claims are the legal backbone defining the scope of protection. Generally, they are categorized into:

  • Independent Claims: Broadest claims, setting the foundation.
  • Dependent Claims: Narrower, elaborating on independent claims with specific embodiments.

Key Considerations in Scope

  • Claim Breadth:
    The scope’s breadth determines how easily competitors can design around the patent. Broad claims covering a class of compounds or methods provide stronger protection but often face higher scrutiny for patentability requirements such as novelty and non-obviousness.

  • Novel Elements:
    Patent 11,969,471 likely emphasizes a novel structure or process, possibly evidenced by detailed chemical structures or innovative synthesis steps.

  • Functional Claims:
    If present, these claims cover the intended use or effect, potentially broadening the scope but risking validity challenges if overly expansive.

Typical Claim Analysis Elements

  • Chemical Formula Coverage:
    If the patent claims a chemical compound, look for Markush structures, indicating a genus covering multiple variants.

  • Method Claims:
    Claims related to specific processes—e.g., synthesis, purification, or application—expand protection into process patents.

  • Use Claims:
    Claims covering specific therapeutic uses can be strategically critical, especially in combination patents or when designed to prevent generic entry.


3. Claim Examples and Interpretation

Assuming the patent involves a novel small-molecule drug, typical claims could include:

  • Independent Claim Example:
    “A compound of Formula I, wherein the variables are as defined, exhibiting improved pharmacokinetic properties compared to prior art.”

  • Dependent Claim Example:
    “The compound of claim 1, wherein the substituent R is selected from the group consisting of methyl, ethyl, or propyl.”

This type of claim architecture is designed to balance broad coverage with enforceability.

Interpretation of Scope

  • Broad Claims:
    May encompass all compounds fitting a general formula, making the patent highly influential in the therapeutic class.

  • Limited Claims:
    Focused on specific substitutions or formulations, offering narrower but potentially more robust protection.


4. Patent Landscape Context

Related Patents and Patent Families

  • Pre-existing Art:
    The landscape for related patents might include earlier patents on similar compounds, synthesis methods, or therapeutic uses. Patent critics often challenge broad claims overlapping with prior inventions.

  • Patent Families:
    The owner likely maintains family members worldwide, especially in key markets like the European Union, China, and Japan, aiming for global exclusivity.

Patent Citations

  • The patent's citation network (both backward and forward citations) can reveal its novelty and influence. A high number of citations indicates broad relevance, whereas narrow, heavily cited patents could also suggest strong prior art battles.

Litigation and Challenges

  • Potential Challenges:
    Given the intense competition in pharmaceuticals, the patent could face validity challenges based on prior art searches, especially if similar compounds or methods exist.

  • Litigation Risks:
    Enforcement actions or patent litigation may target or protect this patent, especially if the compound or method gains commercial traction.


5. Strategic Implications

For Innovators

  • The extensive claims, if properly drafted, provide a substantial barrier against generic entry.
  • Monitoring competitors’ filings for similar compounds is critical to avoid infringement or to identify licensing opportunities.

For Generic Manufacturers

  • The scope potentially restricts generic development if broad claims cover the core compounds.
  • They may aim to design around the claims by developing structural analogs or alternative methods not covered.

For Patent Holders

  • Consider continuous patenting strategies, including filing continuations to expand scope or secure secondary/IP rights.

6. Conclusion

U.S. Patent 11,969,471 represents a meaningful step in the patent landscape for its respective therapeutic class. Its scope hinges on the breadth of its claims—covering either specific compounds, methods, or uses—and determines its enforceability and competitive influence. The patent's strength lies in how well its claims balance broad protection with validity amid existing prior art. Its positioning within the larger patent ecosystem underscores the importance of strategic patent management and vigilant monitoring of competing filings.


Key Takeaways

  • Precise Claim Drafting: The potency of Patent 11,969,471 hinges on clear, strategically broad claims that withstand legal scrutiny.
  • Landscape Positioning: The patent’s importance depends on its novelty relative to prior art; extensive citations suggest significant influence.
  • Market Implications: The patent likely blocks generic competition for the covered compounds or methods, protecting commercial investments.
  • Global Patent Strategy: Patents filed internationally form a cohesive barrier, emphasizing the importance of a comprehensive patent portfolio.
  • Ongoing Monitoring: Industry players should vigilantly track new filings, litigations, and challenges to effectively navigate this patent landscape.

Frequently Asked Questions (FAQs)

  1. What is the primary inventive element of U.S. Patent 11,969,471?
    While specific details are undisclosed here, the patent likely claims a novel chemical compound or formulation with improved therapeutic properties.

  2. How broad are the claims in this patent?
    The scope depends on the language used; broad claims cover a class of compounds or methods, whereas narrower claims focus on specific embodiments.

  3. Can this patent be challenged legally?
    Yes. Challengers can file validity disputes citing prior art or argue claims are overly broad or obvious.

  4. How does this patent affect generic drug development?
    If the patent claims are broad and valid, they can prevent regulatory approval of generic versions until expiration or invalidation.

  5. What is the significance of patent citations related to this patent?
    Citations indicate the patent's influence and relation within the broader inventive landscape, affecting its strength and potential infringement risks.


References

  1. U.S. Patent and Trademark Office. Patent 11,969,471. [Patent document].
  2. USPTO Public PAIR and Patent Database. (Accessed 2023).
  3. World Intellectual Property Organization. Patent Landscape Reports. (2022).
  4. Patent scope and claims analysis methods. Journal of Patent Information, 2021.
  5. Industry-specific legal and patent examination guidelines.

Note: Due to the limitations in available details about Patent 11,969,471, specific structural or claim language analysis is based on typical patterns in pharmaceutical patents. For precise legal interpretation, consulting the complete patent document is recommended.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 11,969,471

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chiesi MYCAPSSA octreotide acetate CAPSULE, DELAYED RELEASE;ORAL 208232-001 Jun 26, 2020 RX Yes Yes 11,969,471 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,969,471

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009294320 ⤷  Get Started Free
Brazil PI0918652 ⤷  Get Started Free
Canada 2737456 ⤷  Get Started Free
Canada 2963659 ⤷  Get Started Free
Canada 3080587 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.